New cancer clinical trial: Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors

Published on: April 27, 2018 at 12:00PM
Conditions:   Advanced Cancer;   Metastatic Cancer;   Neoplasms;   Neoplasm Metastasis;   Neoplastic Processes;   Pathologic Processes
Intervention:   Drug: MRX-2843
Sponsor:   Meryx, Inc.
Not yet recruiting
https://ift.tt/2JuLVFZ